The pharmacokinetics of caffeine in Nigerian children suffering from malaria and kwashiorkor

European Journal of Clinical Pharmacology

Volumn 56, Issue 2, 2000, Pages 153-158

  Akinyinka, O O ^a,b   Sowunmi, A ^b   Honeywell, R ^a   Renwick, A G ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Caffeine; Kwashiorkor; Malaria

Indexed keywords

CAFFEINE; CYTOCHROME P450 ISOENZYME; PARAXANTHINE; XANTHINE DERIVATIVE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KWASHIORKOR; MALARIA; MALE; NIGERIA; PRIORITY JOURNAL; TROPICAL DISEASE;

EID: 0034045131     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050734     Document Type: Article

References (29)

1. Abdel Razzak Z, Loyer P, Fautre A, et al (1993) Cytokines down regulate expression of major cytochrome P450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 44: 707-715
2. Adelusi SA, Dawodu AH, Salako LA (1982) Kinetics of the uptake and elimination of chloroquine in children with malaria. Br J Clin Pharmacol 14: 483-487
3. Akbani Y, Bolme P, Lindblad BS, Rahintoola RJ (1977) Control of streptomycin and streptomycin in malnourished children treated for tuberculosis. Acta Pediatr Scand 66: 237-240
4. Anonymous (1991) Nigeria Bulletin Epidemiology 1: 4
5. Aranda BV, Collinge JM, Zinman R, Waters G (1979) Maturation of caffeine in infancy. Arch Dis Childh 54: 946-949
6. Bamgboye EA, Familusi JB (1990) Mortality pattern at a children's emergency ward, University College Hospital, Ibadan, Nigeria. Afr J Med Med Sci 19: 127-132
7. Carrier O, Pons G, Key E, Richard MO, Moran C, et al (1988) Maturation of caffeine metabolic pathways in infancy. Clin Pharmacol Ther 55: 293-304
8. Dobrocky P, Bennett PN, Notariani LJ (1994) Rapid method for the determination of caffeine and its metabolites by high performance liquid chromatography. J Chromatogr B 652: 104-108
9. Eriksson M, Paalzow L, Bolme P, Mariam TW (1983a) Chloramphenicol pharmacokinetics in Ethiopian children of different nutritional status. Eur J Clin Pharmacol 24: 819
10. Eriksson M, Paalzow L, Bolme P, Mariam TW (1983b) Pharmacokinetics of theophylline in Ethiopian children of differing nutritional status. Eur J Clin Pharmacol 24: 89-92
11. Fuhr U, Rost KL (1994) Simple and reliable CYP1A2 phenotyping by the paraxanthine:caffeine ratio in plasma and saliva. Pharmacogenetics 4: 109-116
12. Karney WW, Tong MJ (1972) Malabsorption in Plasmodium falciparum malaria. Am J Trop Med Hyg 21: 1-5
13. Kearns GL, Reed MD (1989) Clinical pharmacokinetics in infants and children: a reappraisal. Clin Pharmacokinet 17[Suppl 1]: 29-67
14. Kokwaro GO, Glazier AP, Ward SA, Breckenridge AM, Edwards G (1993) Effect of malaria infection and endotoxin induced fever on the metabolism of antypyrine and metronidazole in the rat. Biochem Pharmacol 45: 1243-1249
15. Koren G, James A, Perlman M (1985) A simple method for the estimation of glomerular filtration rate by gentamycin pharmacokinetics during routine drug monitoring in the new-born. Clin Pharmacol Ther 38: 680-685
16. Lelo RA, Birkett DJ, Robson RA, Miners JO (1986) Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Br J Clin Pharmacol 22: 177-182
17. Masimirembwa CM, Beke M, Hasler JA, Tang B-K, Kalow W (1995) Low CYP1A2 activity in rural Shona children of Zimbabwe. Clin Pharmacol Ther 57: 25-31
18. Mehta S, Naim CK, Kalsi HK, Mathur S (1981) Bioavailability and pharmacokinetics of chloramphenicol palmitate in malnourished children. Indian J Med Res 74: 244-250
19. Monshower M, Witkamo RF, Nijmeijer SM (1995) Infection (Actinobacillus pleuropneumoniae) mediated suppression of oxidative hepatic drug metabolising and cytochrome P450 3A mRNA levels in pigs. Drug Metab Dispos 23: 44-47
20. Neims AH, Warner M, Loughnan PM, Aranda JV (1976) Developmental aspect of hepatic cytochrome P450 monoxygenase system. Ann Rev Pharmacol Toxicol 16: 425-445
21. Powell JR, Cate WK (1986) Induction and inhibition of metabolism. In: Evans WK, Schentag JJ (eds) Applied therapeutics. Spokane, Washington, pp 139-186
22. Renwick AG (1998) Toxicokinetics in infants and children in relation to the ADI and TDI. Food Additives and Contaminants 15[Suppl]: 17-35
23. Sowunmi A (1996) The disposition of oral quinine in African patients suffering from acute uncomplicated falciparum malaria. E Afr Med J 73: 25-29
24. Salako LA, Sowunmi A, Akinbami FO (1989) Pharmacokinetics of quinine in African children from kwashiorkor. Br J Clin Pharmacol 28: 197-201
25. Tand DDS, Williams RL, Riegleman S (1983) Disposition of caffeine and its metabolite in man. J Pharmacol Exp Ther 224: 180-185
26. Walker O, Dawodu AH, Salako LA, Alvan G, Johnson AOK (1987) Single dose disposition of chloroquine in kwashiorkor and normal children; evidence of decreased absorption in kwashiorkor. Br J Clin Pharmacol 23: 467-472
27. White NJ, Miller KD, Churchill FC, et al (1988) Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity and new dosage recommendation. N Engl J Med 319: 1493-1500
28. Wilaitarana P, Locareesowan, Vanijanonta S, Charoenlarp P, Wilaitarana P (1994) Hepatic metabolism in severe malaria: caffeine clearance study. Am Trop Med Parasitol 88: 13-19
29. Wynne H, Cope L, Herd B, Rawlins M, James O, Woolhouse K (1990) The association of age and frailty with paracetamol conjugation in man. Age Ageing 19: 419-424